Down Round Explained: Triggers, Terms, and 2026 Rates

What happens to each shareholder when the price drops, and how investors decide whether to fund one

Venture Capital10 min read
Down Round Explained: Triggers, Terms, and 2026 Rates

A down round is a financing in which a company sells shares at a lower price per share than in its previous round. Anti-dilution protection often shifts part of the cost onto common holders, and the new investor usually arrives with leverage to reset terms. Down rounds made up 11.4 percent of rounds in Carta's Q1 2026 data and 12.1 percent of Cooley's Q2 2026 deals.

Definition: A down round is an equity financing priced below the company's prior round: the new price per share is lower, and the new pre-money valuation is below the previous round's post-money valuation.

A down round is rarely where the problem starts. It's where the problem gets a price.

Illustrative worked example: A company raised a $5M Series A at $2.00 per share, a $25M post-money valuation on 12,500,000 fully diluted shares. Growth stalls, and a new investor offers $4M at $1.00 per share, a $12.5M pre-money valuation. Under a broad-based weighted average anti-dilution clause, the Series A conversion price falls from $2.00 to about $1.76, so the 2,500,000 preferred shares now convert into roughly 2,845,000 common shares. The other 10,000,000 shares, mostly founders and employees, fall from 80 percent to about 59.4 percent: 60.6 percent from the 4,000,000 new shares alone, and the rest from the roughly 345,000 extra shares issued to the Series A. Under full ratchet, the same holders would drop to about 52.6 percent.

What triggers a down round

A round is "down" if the price per share falls, even when the headline valuation looks similar. Carta's guide lists internal problems (missed revenue targets, lawsuits, competition), market downturns, and sector-specific investor scrutiny as common causes. We group them into four patterns:

  1. A missed plan. The company raised on a forecast and delivered half of it.
  2. A market reset. The company grew, but valuation multiples fell faster, so a price set in a hotter market is hard to match.
  3. An over-priced prior round. The last round was arguably the mistake, and the down round is the correction. Our guide to seed valuations and venture return math shows how to choose a price you can grow into, and our take on the $100M pre-seed problem covers what too much money too early can do to discipline.
  4. A distressed insider round. No outside lead exists, and insiders reprice to fund a turnaround.

How common down rounds are in 2026

Down rounds peaked after the 2021 boom and have been falling since. Carta's State of Private Markets report for Q1 2026 put the down-round rate at 11.4 percent, back in line with 2019 and 2020 levels, after a peak of 22 percent in 2023. In Q4 2025 Carta counted fewer than 14 percent, then the lowest rate in three years.

Cooley's Q2 2026 Venture Financing Report, covering 166 deals, shows 83.6 percent up rounds, 4.3 percent flat, and 12.1 percent down, compared with 10.9 percent down in Q1 2026. For context, Carta's down round guide puts the average from Q1 2015 to Q3 2022 at 10.6 percent. Today's rate is close to the long-run norm.

Two related terms from Cooley's Q2 2026 data: pay-to-play provisions appeared in 8.4 percent of deals, up from about 7 percent in Q1, and recapitalizations in 1.8 percent.

What a down round does to each shareholder

Preferred investors with anti-dilution protection. Their conversion price drops, so they receive more common shares on conversion. The broad-based weighted average version produces a moderate adjustment; full ratchet resets the price entirely. The guide to the anti-dilution provision walks through the formula.

Founders and employees. They absorb the new shares and the adjustment, as the worked example shows.

The new investor. Buys at the lower price and may ask for richer terms, such as a senior or multiple liquidation preference, a larger option pool, board changes, or a pay-to-play provision.

Existing funds. Cooley GO notes that venture funds report to their limited partners based on portfolio value, so existing investors may have to write down their holdings after a down round. That's one reason insiders resist a lower price even when it is fair.

Down round effects on employee options and the 409A

A down round hits employees twice: dilution, and options that may now be underwater. Carta's guide warns that options priced above the current share price can become worthless if the price does not recover.

  • Get a new 409A valuation. Carta's 409A guide lists closing a new financing round as a material event that calls for a fresh valuation, and a 409A is valid for at most 12 months in any case. New grants should use the new fair market value.
  • Consider a repricing. Cooley GO explains that a simple repricing lowers the exercise price and leaves other terms unchanged, and that the new price for US taxpayers must be at least the fair market value on the repricing date. Board approval is required; stockholder approval depends on the plan.
  • Watch the ISO rules. Per Cooley GO, repricing an ISO counts as a new grant, which restarts the holding periods and retests the $100,000 annual limit, so some options may become nonqualified.
  • Mind the tender offer rules. If other terms change too, Cooley GO notes the offer may need to follow tender offer rules, including staying open at least 20 business days.

How an investor might evaluate a down round

For the new investor:

  1. Confirm the trigger: real traction with a stale price, or a broken model?
  2. Model the fully diluted post-round table with every anti-dilution adjustment applied, and ask existing investors whether they will waive or reduce theirs. Cooley GO lists negotiating such waivers as one way to soften a down round.
  3. Check the preference stack. If total preferences exceed any realistic exit value, common is worth little and the team has less reason to stay.
  4. Budget for a pool refresh or option repricing so the team is re-motivated at the new price.
  5. Price honestly. A down round that is still too high can produce another one.

For existing investors:

  1. Decide whether to participate before the terms arrive, since pay-to-play can penalize waiting.
  2. Weigh the waiver. Enforcing full anti-dilution on a team diluted to indifference can end up protecting a percentage of a company that stops growing. We'd rather own a bit less of something alive.
  3. Read senior preferences ahead of yours for what they do to your recovery in a modest exit.
  4. Consider a bridge round instead if a milestone is genuinely close.

Alternatives to a down round

Cooley GO lists a bridge financing on convertible notes and other investor-friendly terms (a liquidation preference, dividends, or warrant coverage) as ways to avoid or soften a lower price, and Carta's guide adds tranched financing tied to milestones and venture debt. Tranches are common in life sciences: Cooley's Q2 2026 report found them in 29.6 percent of life sciences deals. A recapitalization that resets the cap table is the heavier option, and it remains rare (1.8 percent of Cooley's Q2 2026 deals).

Each has a cost. The new lead will likely also renegotiate the protective provisions.

"Shouldn't you avoid a down round at almost any cost?"

That's the instinct in most boardrooms. A lower price stings, it can spook employees and future investors, and a flat round with some extra structure keeps the headline number intact. Nobody wants the word "down" in the press release.

But Structure that hides a down round often costs common holders more than an honest price would have. A flat round with a 2x participating preference can leave common worse off than a modest down round with clean terms. The headline survives. The founders' and employees' payout doesn't. In our view, a clean reset the team can grow out of usually beats a flattering price with a trapdoor under it.

Investors who want to see these trade-offs argued on live companies can join 1752vc's Emerging Angels program, an eight-week program for accredited investors with live diligence calls, deal reviews, and monthly Investment Circles.

The bottom line

Price the round honestly, model every adjustment, fix the option pool, and keep the preference stack small enough that common still has a reason to show up.

A flattering price wins the week.

Clean terms win the exit.

Key takeaways

  • A down round is a financing at a lower price per share than the prior round, and it triggers anti-dilution adjustments that shift dilution onto founders and employees.
  • Carta reported an 11.4 percent down-round rate in Q1 2026 and Cooley 12.1 percent of Q2 2026 deals, close to the 10.6 percent long-run average after a 22 percent peak in 2023.
  • Carta treats a new financing as a 409A material event, so new grants generally need a fresh valuation, and under the tax rules any repricing for US taxpayers has to be at or above the new fair market value.
  • The new investor's diligence often focuses on the trigger, the preference stack, anti-dilution waivers, and re-motivating the team.
  • Existing investors may want to decide early whether to participate, because pay-to-play provisions (8.4 percent of Cooley's Q2 2026 deals) strip rights from those who do not.

Frequently asked questions

A down round is a financing in which a startup sells shares at a lower price per share than in its previous round, so the new pre-money valuation is below the last post-money valuation. Because many preferred investors hold anti-dilution protection, a down round usually dilutes founders and employees more than the new share count alone suggests.

Roughly one priced round in eight. Carta's State of Private Markets report put the down-round rate at 11.4 percent in Q1 2026, and Cooley's Q2 2026 Venture Financing Report counted 12.1 percent of its 166 deals as down rounds. Both are well below the 22 percent peak Carta recorded in 2023.

Options with an exercise price above the new share price are typically underwater, and employees are diluted by the new shares and any anti-dilution adjustment. Companies often respond with fresh grants at the new 409A price or a repricing of existing options. Repriced ISOs are treated as new grants, which restarts their holding periods.

In practice, yes. Carta's 409A guide lists closing a new financing round as a material event that calls for a fresh valuation, and a lower preferred price usually means a lower common value. Granting or repricing options off a stale, higher 409A can waste value for employees, while granting below current fair market value creates tax risk.

For existing investors, a down round usually means a write-down and new terms that may sit ahead of theirs. For a new investor, it can be an attractive entry price if the company's problem was its prior valuation rather than its business, and if the team stays motivated after the reset.

Sources

Disclaimer: This guide is for general education only and is not legal, tax or investment advice. Laws, market data and program terms change, so it may not reflect the latest developments or fit your situation. Treat it as a starting point, not a source of truth, and talk to a qualified lawyer, accountant or financial adviser before you make decisions.